Earnings History Data for Aclaris Therapeutics (ACRS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | ACRS | Aclaris Therapeutics | 155.00 | -0.11 | -0.08 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.11 misses by $0.05, revenue of $4.35M misses by $7.5M [11/6/2024 7:24 AM] |
2.27 | 0.04 (2.03%) |
2.21 | -0.01 (-0.45%) |
0.59 - 5.70 | 519,678 | 1,650,000 | 10,958 | ||
| 07-08-2024 | PM | ACRS | Aclaris Therapeutics | 88.00 | -0.15 | -0.19 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.15, revenue of $2.8M [8/7/2024 9:17 AM] |
1.20 | -0.02 (-2.05%) |
1.26 | 0.04 (3.69%) |
0.59 - 9.95 | 1,193,148 | 610,000 | 1,090 | ||
| 07-05-2024 | AH | ACRS | Aclaris Therapeutics | 93.00 | -0.24 | -0.28 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.24 beats by $0.03, revenue of $2.4M beats by $0.4M [5/7/2024 4:04 PM] |
1.22 | -0.12 (-9.33%) |
1.26 | -0.08 (-5.97%) |
0.59 - 11.12 | 1,146,446 | 900,000 | 32,131 | ||
| 27-02-2024 | PM | ACRS | Aclaris Therapeutics | 84.00 | -0.30 | -0.37 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.02 beats by $0.31, revenue of $17.6M beats by $12.55M [2/27/2024 7:17 AM] |
1.20 | -0.01 (-1.24%) |
1.25 | 0.04 (3.27%) |
0.59 - 12.93 | 2,657,621 | 1,120,000 | 12,871 | ||
| 06-11-2023 | PM | ACRS | Aclaris Therapeutics | 359.00 | -0.41 | -0.48 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.41 beats by $0.07, revenue of $9.28M [11/6/2023 7:20 AM] |
5.51 | 0.14 (2.61%) |
5.66 | 0.29 (5.40%) |
4.33 - 18.96 | 836,987 | 1,410,000 | 1,906 | ||
| 07-08-2023 | PM | ACRS | Aclaris Therapeutics | 695.00 | -0.42 | -0.45 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.42 beats by $0.03, revenue of $1.87M misses by $0.03M [8/7/2023 7:17 AM] |
9.15 | -0.70 (-7.11%) |
0.0 | 0.0 (0.00%) |
5.77 - 18.96 | 551,496 | 400,000 | 0 | ||
| 08-05-2023 | PM | 7:00 AM ET (May 8) |
ACRS | Aclaris Therapeutics, Inc. | 625.51 | -0.42 | -0.44 | -0.31 | Aclaris Therapeutics GAAP EPS of -$0.42 beats by $0.02, revenue of $2.53M beats by $0.78M [5/8/2023 7:03 AM] |
8.43 | -0.55 (-6.18%) |
8.34 | -0.64 (-7.13%) |
5.77 - 18.96 | 1,045,534 | 650,000 | 16,643 | |
| 03-08-2022 | PM | 7:00 AM ET (Aug 3) |
ACRS | Aclaris Therapeutics | 907.00 | -0.31 | -0.36 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.31 beats by $0.05, revenue of $1.53M misses by $0.08M [8/3/2022 7:57 AM] |
14.43 | 0.23 (1.62%) |
0.0 | 0.0 (0.00%) |
9.26 - 19.97 | 228,753 | 240,000 | 0 | |
| 10-05-2022 | PM | 7:00 AM ET (May 10) |
ACRS | Aclaris Therapeutics | 724.00 | -0.31 | -0.39 | 0.00 | Aclaris Therapeutics GAAP EPS of -$0.31 beats by $0.09, revenue of $1.45M misses by $0.22M [5/10/2022 7:20 AM] |
11.18 | 0.03 (0.27%) |
11.15 | 0.0 (0.00%) |
9.26 - 24.00 | 214,295 | 476,635 | 16,459 | |
|
||||||||||||||||||
| 02-11-2021 | PM | ACRS | Aclaris Therapeutics | 1,062 | -0.35 | -0.27 | 0.00 | Aclaris Therapeutics EPS misses by $0.07, misses on revenue [11/2/2021 7:40 AM] |
16.48 | -2.01 (-10.87%) |
17.75 | -0.74 (-4.00%) |
3.04 - 30.38 | 788,943 | 320,000 | 6,934 | ||
| 05-08-2021 | PM | ACRS | Aclaris Therapeutics, Inc. | 777.00 | -0.34 | -0.26 | 0.00 | Aclaris Therapeutics EPS misses by $0.06, beats on revenue [8/5/2021 7:53 AM] |
14.77 | 0.46 (3.21%) |
14.31 | 0.0 (0.00%) |
1.82 - 30.38 | 242,697 | 350,000 | 4,058 | ||
| 07-05-2021 | PM | ACRS | Aclaris Therapeutics, Inc. | 1,230 | -0.57 | -0.27 | -0.36 | Aclaris Therapeutics EPS misses by $0.29, beats on revenue [5/7/2021 7:39 AM] |
22.95 | -0.88 (-3.69%) |
22.95 | 0.0 (0.00%) |
1.16 - 30.38 | 434,604 | 540,000 | 8,188 | ||
| 04-11-2020 | PM | 7:00 AM ET (Nov 4) |
ACRS | Aclaris Therapeutics, Inc. | 160.00 | -0.25 | -0.29 | 0.00 | Aclaris Therapeutics EPS beats by $0.05, misses on revenue [11/4/2020 7:15 AM] |
3.98 | 0.27 (7.28%) |
0.0 | 0.0 (0.00%) |
0.70 - 5.04 | 331,185 | 203,298 | 0 | |
|
|
||||||||||||||||||
| 04-11-2020 | PM | 7:00 AM ET (Nov 4) |
ACRS | Aclaris Therapeutics, Inc. | 158.95 | -0.25 | -0.29 | -0.56 | Aclaris Therapeutics EPS beats by $0.05, misses on revenue [11/4/2020 7:15 AM] |
4.12 | 0.15 (3.78%) |
3.86 | -0.11 (-2.77%) |
0.70 - 5.04 | 218,067 | 200,783 | 300 | |
|
|
||||||||||||||||||